6-Mercaptopurine attenuates adhesive molecules in experimental vasospasm

Acta Neurochir (Wien). 2010 May;152(5):861-7. doi: 10.1007/s00701-010-0602-0. Epub 2010 Mar 2.

Abstract

Objective: Adhesion molecules, including intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin, are important inflammatory mediators which are elevated in the serum of patients following aneurysmal subarachnoid hemorrhage (SAH). The authors previously found that 6-mercaptopurine (6-mp) was effective in preventing and reversing arterial narrowing in a rodent SAH model. The present study was to examine whether levels of adhesion molecules were altered after treatment with 6-mp in this animal model.

Materials and methods: Animals were each injected with autologous blood into the cisterna magna, and intraperitoneal treatment with 6-mp (2 mg/kg) was initiated 1 h before (prevention) or later (treatment). The compound was subsequently administered at 24 and 48 h post-SAH. Blood samples were collected at 72 h post-SAH to measure ICAM-1, VCAM-1, and E-selectin levels. The basilar arteries were harvested and sliced, and their cross-sectional areas were measured. Morphologically, convolution of the internal elastic lamina, distorted endothelial wall, and myonecrosis of the smooth muscle were prominently observed in the SAH only and vehicle-treated SAH groups, but not in the 6-mp-treated SAH group or in healthy controls. No significant differences were found in the levels of VCAM-1 among all groups. However, the levels of E-selectin were increased in all animals subjected to SAH (SAH only and SAH plus vehicle groups) compared with healthy controls (no SAH), but not in the 6-mp group (SAH plus 6-mp treatment and preventive treatment with 6-mp).Likewise, the levels of ICAM-1 in the SAH only and SAH plus vehicle groups were significantly elevated (p < 0.001), and pretreatment and treatment with 6-mp reduced ICAM-1 to control levels.

Conclusion: These results show that ICAM-1 and E-selectin may play a role in mediating SAH-induced vasospasm and that a reduction of both adhesive molecules after SAH may partly contribute to the antispastic effect of 6-mp.

MeSH terms

  • Animals
  • Antimetabolites / pharmacology*
  • Antimetabolites / therapeutic use
  • Basilar Artery / drug effects
  • Basilar Artery / metabolism
  • Basilar Artery / pathology
  • Cell Adhesion Molecules / antagonists & inhibitors*
  • Cerebral Arteries / drug effects*
  • Cerebral Arteries / metabolism
  • Cerebral Arteries / physiopathology
  • Disease Models, Animal
  • E-Selectin / drug effects
  • E-Selectin / metabolism
  • Inflammation Mediators / antagonists & inhibitors
  • Inflammation Mediators / metabolism
  • Intercellular Adhesion Molecule-1 / drug effects
  • Intercellular Adhesion Molecule-1 / metabolism
  • Male
  • Mercaptopurine / pharmacology*
  • Mercaptopurine / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Subarachnoid Hemorrhage / complications*
  • Treatment Outcome
  • Up-Regulation / drug effects
  • Up-Regulation / physiology
  • Vascular Cell Adhesion Molecule-1 / drug effects
  • Vascular Cell Adhesion Molecule-1 / metabolism
  • Vasodilation / drug effects
  • Vasodilation / physiology
  • Vasospasm, Intracranial / drug therapy*
  • Vasospasm, Intracranial / metabolism
  • Vasospasm, Intracranial / physiopathology

Substances

  • Antimetabolites
  • Cell Adhesion Molecules
  • E-Selectin
  • Inflammation Mediators
  • Vascular Cell Adhesion Molecule-1
  • Intercellular Adhesion Molecule-1
  • Mercaptopurine